Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Bode

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Diabetes Technology & Therapeutics|September 13, 2021
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE StudySatish K Garg, David Liljenquist, Bruce Bode, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 3, 2012
TheV-Go insulin delivery device used in clinical practice: patient perception and retrospective analysis of glycemic controlCheryl R Rosenfeld, Nancy J Bohannon, Bruce Bode, et al.
BMJ Open Diabetes Research & Care|April 19, 2020
Glycemic responses to strenuous training in male professional cyclists with type 1 diabetes: a prospective observational studyOlivia McCarthy, Max L Eckstein, Sam N Scott, et al.
Plos One|July 30, 2010
Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes riskHongjie Wang, Yulan Jin, M V Prasad Linga Reddy, et al.
Frontiers in Immunology|April 19, 2021
Serum Levels of Inflammatory Proteins Are Associated With Peripheral Neuropathy in a Cross-Sectional Type-1 Diabetes CohortSharad Purohit, Paul Minh Huy Tran, Lynn Kim Hoang Tran, et al.
Diabetes Technology & Therapeutics|April 7, 2021
An Evaluation of Two Capillary Sample Collection Kits for Laboratory Measurement of HbA1cRoy W Beck, Laura E Bocchino, John W Lum, et al.
Lancet (London, England)|July 2, 2011
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trialNicole Sherry, William Hagopian, Johnny Ludvigsson, et al.
Diabetes Technology & Therapeutics|June 28, 2022
Accuracy of Three Commercial Home-Use Hemoglobin A1c TestsLaura M Jacobsen, Laura E Bocchino, John W Lum, et al.
Human Molecular Genetics|October 18, 2008
IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cellsSiyang Liu, Hongjie Wang, Yulan Jin, et al.
The Lancet. Diabetes & Endocrinology|January 28, 2017
Exercise management in type 1 diabetes: a consensus statementMichael C Riddell, Ian W Gallen, Carmel E Smart, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Diabetes Technology & Therapeutics|September 13, 2021
Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE StudySatish K Garg, David Liljenquist, Bruce Bode, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 3, 2012
TheV-Go insulin delivery device used in clinical practice: patient perception and retrospective analysis of glycemic controlCheryl R Rosenfeld, Nancy J Bohannon, Bruce Bode, et al.
BMJ Open Diabetes Research & Care|April 19, 2020
Glycemic responses to strenuous training in male professional cyclists with type 1 diabetes: a prospective observational studyOlivia McCarthy, Max L Eckstein, Sam N Scott, et al.
Plos One|July 30, 2010
Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes riskHongjie Wang, Yulan Jin, M V Prasad Linga Reddy, et al.
Frontiers in Immunology|April 19, 2021
Serum Levels of Inflammatory Proteins Are Associated With Peripheral Neuropathy in a Cross-Sectional Type-1 Diabetes CohortSharad Purohit, Paul Minh Huy Tran, Lynn Kim Hoang Tran, et al.
Diabetes Technology & Therapeutics|April 7, 2021
An Evaluation of Two Capillary Sample Collection Kits for Laboratory Measurement of HbA1cRoy W Beck, Laura E Bocchino, John W Lum, et al.
Lancet (London, England)|July 2, 2011
Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trialNicole Sherry, William Hagopian, Johnny Ludvigsson, et al.
Diabetes Technology & Therapeutics|June 28, 2022
Accuracy of Three Commercial Home-Use Hemoglobin A1c TestsLaura M Jacobsen, Laura E Bocchino, John W Lum, et al.
Human Molecular Genetics|October 18, 2008
IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cellsSiyang Liu, Hongjie Wang, Yulan Jin, et al.
The Lancet. Diabetes & Endocrinology|January 28, 2017
Exercise management in type 1 diabetes: a consensus statementMichael C Riddell, Ian W Gallen, Carmel E Smart, et al.
Pageof 7